Innovations in the external therapy of acne

Cite item


Goal. To assess the clinical efficacy of a monotherapy with the use of products belonging to the Hyseac line for the treatment of light acne. Materials and methods. The study involved 28 patients with light acne, who were administered products belonging to the Hyseac line as a monotherapy. The dynamics of the skin processes was assessed visually (S. Liden’s acne general severity scale) and with the use of instrumental methods — sebometry (Callegari SOFT 5.5). Results. High efficacy of the administered therapy was registered in 39% of the subjects, substantial improvement was recorded in 53% of the subjects, improvement — in 8% of the subjects while no effect was registered in 0% of the subjects. Conclusion. The drug demonstrated high clinical efficacy, good tolerance and absence of any adverse effects, which makes it possible to recommend products belonging to the Hyseac line as a monotherapy and concomitant treatment of light acne.

Full Text

Инновации в наружной терапии акне

About the authors

M M Tlish

Kuban State Medical University

Sedina str., bldg 4, 350063, Krasnodar, Russia

O A Katkhanova

Kuban State Medical University

Sedina str., bldg 4, 350063, Krasnodar, Russia

T G Kuznetsova

Kuban State Medical University

Sedina str., bldg 4, 350063, Krasnodar, Russia

Zh Yu Naatyzh

Kuban State Medical University

Sedina str., bldg 4, 350063, Krasnodar, Russia


  1. Akne i rozatsea. Pod red. N.N. Potekaeva. M: Binom 2007; 215.
  2. Kubanova A.A., Samsonov V.A., Zabnenkova O.V. Sovremennye osobennosti patogeneza i terapii akne. Vestn dermatol i venerol 2003; 1: 9—16.
  3. Josipovitch G., Tang M., Dawn F.G. et al. Study of psychological stress, sebum production and acne vulgaris in adolescencents. Acta Dermato-Venerologica 2007; 87: 135—139.
  4. Esterbauer H., Gebicki J., Puhl H. The role of lipid peroxidation and antioxidants in oxidative modification of LDF. Free Radic Biol Med 1992; 13: 341—390.
  5. Plewig G. Acne and rosacea / G. Plewig, A.M. Kligman. Berlin 1993; 555—673.
  6. ONeil D.A., Porter E.M., Elewaut D. et al. Expression and regulation of the human beta-defensins hBD-1 and hBD-2 in intestinal epithelium. J Immunol 1999; 163: 6718—24.
  7. Schwandner R., Dziarski R., Wesche H., Rothe M., Kirschning C.J. Peptidoglycan- and lipoteichoic acid-induced cell activation is mediated by toll-like receptor 2. J Biol Chem 1999; 274: 17406—9.
  8. Skripkin Yu.K. i dr. Kozhnye i venericheskie bolezni: rukovodstvo dlya vrachey. M: Meditsina 1995; 2: 17—19.
  9. Zimina I.V., Lopukhin Yu.M., Arion V.Ya. Kozha kak immunnyy organ: kletochnye elementy i tsitokiny. Immunologiya 1994; 1: 8—13.
  10. Strcinlein J.W. Skin — associated limfoid tissue (SALT): original and function. J Invest Dermatol 1983; 80: 12—16.
  11. Yutskovskaya Ya.A., Mel'nikova E.V., Metlyaeva N.B. Otsenka sostoyaniya psikhoemotsional'noy sfery u bol'nykh akne. Vestn dermatol i venerol 2005; 3: 48—49.

Copyright (c) 2013 Tlish M.M., Katkhanova O.A., Kuznetsova T.G., Naatyzh Z.Y.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 60448 от 30.12.2014.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies